Angiogenic molecular signature in colorectal cancer: Pharmacogenomic implications for the use of antiangiogenic therapies

by Abajo, A. (Ana), Bandres, E. (Eva), Garcia-Foncillas, J. (Jesús)
Published 2014

Identification of colorectal cancer metastasis markers by an angiogenesis-related cytokine-antibody array

by Abajo, A. (Ana), Bitarte, N. (Nerea), Zarate, R. (Ruth), Boni, V. (Valentina), Lopez, I. (Inés), Gonzalez-Huarriz, M. (Marisol), Rodriguez, J. (Javier), Bandres, E. (Eva), Garcia-Foncillas, J. (Jesús)
Published 2014

Identification of predictive circulating biomarkers of bevacizumab-containing regimen efficacy in pre-treated metastatic colorectal cancer patients

by Abajo, A. (Ana), Boni, V. (Valentina), Lopez, I. (Inés), Gonzalez-Huarriz, M. (Marisol), Bitarte, N. (Nerea), Rodriguez, J. (Javier), Zarate, R. (Ruth), Bandres, E. (Eva), Garcia-Foncillas, J. (Jesús)
Published 2014

Dose-finding study and pharmacogenomic analysis of fixed-rate infusion of gemcitabine, irinotecan and bevacizumab in pretreated metastatic colorectal cancer patients

by Abajo, A. (Ana), Rodriguez, J. (Javier), Bitarte, N. (Nerea), Zarate, R. (Ruth), Boni, V. (Valentina), Ponz-Sarvise, M. (Mariano), Chopitea, A. (Ana), Bandres, E. (Eva), Garcia-Foncillas, J. (Jesús)
Published 2014